Abdul Khan, MD
Gastroenterology · New Orleans, LANPI 1881697134
Payments from drug & device makers
Across 128 payments — averaging $26.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Sanofi-aventis U.S. LLC$1K
- Lumendi LLC$185
- Bristol Myers Squibb$172
- Intercept Pharmaceuticals, Inc.$73
- Takeda Pharmaceuticals U.S.A., Inc.$51
- plus $359 from 15 others
What the payments were for
- Speaking & faculty fees$1,10733%
- Food & beverage$2,22867%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 86 | $1,388 |
| Sanofi-aventis U.S. LLC | 1 | $1,107 |
| Lumendi LLC | 1 | $185 |
| Bristol Myers Squibb | 11 | $172 |
| Intercept Pharmaceuticals, Inc. | 4 | $73 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $51 |
| Boston Scientific | 1 | $49 |
| Ironwood Pharmaceuticals, Inc | 2 | $39 |
| Sanofi | 2 | $35 |
| Phathom Pharmaceuticals, Inc. | 2 | $35 |
| Merck | 2 | $33 |
| GSK | 1 | $24 |
| Alfasigma USA, Inc. | 1 | $24 |
| Regeneron Healthcare Solutions, Inc. | 1 | $23 |
| Novo Nordisk | 1 | $23 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $18 |
| Johnson & Johnson | 1 | $15 |
| ERBE USA Inc | 1 | $15 |
| Lilly USA, LLC | 1 | $12 |
| Redhill Biopharma Inc. | 1 | $11 |
| Gastrogpo, LLC | 4 | $0 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SOLIQUA 100/33$1,107
- DiLumen$185
How this compares
$3,335 in reported general payments places this provider in the 45th percentile of 254 gastroenterology providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LinzessLinaclotide | 58 | $47,222 |
| ClenpiqSod Picosulf/Mag Ox/Citric Ac | 90 | $14,608 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 212 | $3,524 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 35 | $2,460 |
| SutabSod Sulf/Pot Chloride/Mag Sulf | 13 | $2,139 |
| Pantoprazole Sodium | 427 | $2,130 |
| Mesalamine | 16 | $1,892 |
| Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl | 76 | $1,081 |
| Famotidine | 41 | $586 |
| Colestipol Hcl | 12 | $529 |
| Omeprazole | 41 | $498 |
| Dicyclomine Hcl | 38 | $489 |
| Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine | 25 | $366 |
| Promethazine Hcl | 14 | $153 |
| Alprazolam | 12 | $51 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLinzess | $1,388 | $47,22258 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 254 gastroenterology providers in Louisiana.
Other gastroenterology in New Orleans
- Vivek HuilgolNew Orleans$1.6M
- Sarah GloverNew Orleans$1.2M
- Shamita ShahNew Orleans$479K
- Nisha LoganantharajNew Orleans$173K
- Janak ShahNew Orleans$100K
- Virendra JoshiNew Orleans$81K
- Luis BalartNew Orleans$70K
- Vallisitaram KodaliNew Orleans$29K
- Arnab RayNew Orleans$26K
- Stephen LandreneauNew Orleans$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.